CLEC17A

Chr 19

C-type lectin domain containing 17A

CLEC17A encodes a cell surface receptor that binds glycans with terminal alpha-linked mannose or fucose residues and may facilitate carbohydrate-mediated cell communication in germinal centers. Mutations cause autosomal recessive primary immunodeficiency with susceptibility to viral infections and warts. The gene shows no intolerance to loss-of-function variants, consistent with the recessive inheritance pattern observed clinically.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
3
Pubs (1 yr)
14
P/LP submissions
0%
P/LP missense
0.94
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryCLEC17A
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
14 unique Pathogenic / Likely Pathogenic· 43 VUS of 76 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.94LOEUF
pLI 0.000
Z-score 1.79
OE 0.61 (0.410.94)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
0.88Z-score
OE missense 0.82 (0.720.94)
162 obs / 196.8 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.61 (0.410.94)
00.351.4
Missense OE0.82 (0.720.94)
00.61.4
Synonymous OE0.72
01.21.6
LoF obs/exp: 15 / 24.6Missense obs/exp: 162 / 196.8Syn Z: 1.80
DN
0.78top 25%
GOF
0.86top 5%
LOF
0.2386th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

76 submitted variants in ClinVar

Classification Summary

Pathogenic13
Likely Pathogenic1
VUS43
Likely Benign7
13
Pathogenic
1
Likely Pathogenic
43
VUS
7
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
13
0
13
Likely Pathogenic
0
0
1
0
1
VUS
0
39
4
0
43
Likely Benign
0
6
1
0
7
Benign
0
0
0
0
0
Total04519064

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

CLEC17A · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →